Robert Tansley

Robert Tansley is a Partner at Cambridge Innovation Capital plc, focusing on investments in life sciences and technology companies affiliated with the University of Cambridge since January 2014. Tansley serves as a Board Member for various organizations, including T-Therapeutics Ltd, Pretzel Therapeutics, Exvastat, Microbiotica, and ABCODIA LIMITED, all dedicated to advancing medical treatments and technologies. Additionally, Tansley held roles at PetMedix and CMR Surgical, contributing to innovations in animal health and minimally invasive surgery, respectively. Tansley also has experience as a Board Observer at Carrick Therapeutics and has served on the board of Inivata, a liquid biopsy company. Tansley holds an M.Phil in Epidemiology & Biostatistics from the University of Cambridge, an MBA from London Business School, and an MBBS from UCL, along with several other medical and pharmaceutical qualifications.